0001171000-15-000043.txt : 20150702
0001171000-15-000043.hdr.sgml : 20150702
20150702131626
ACCESSION NUMBER: 0001171000-15-000043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150701
FILED AS OF DATE: 20150702
DATE AS OF CHANGE: 20150702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: NATL INST FOR BIOPROCESSING RESEARCH
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK CO. DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILES COLIN
CENTRAL INDEX KEY: 0001632546
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 15968415
MAIL ADDRESS:
STREET 1: C/O NEXVET BIOPHARMA PLC, NATL INSTITUTE
STREET 2: FOSTERS AVENUE, MOUNT MERRION
CITY: BLACKROCK
STATE: L2
ZIP: 00000
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-07-01
0001618561
Nexvet Biopharma plc
NVET
0001632546
GILES COLIN
C/O NEXVET BIOPHARMA PLC
NIBRT; FOSTERS AVENUE, MOUNT MERRION
BLACKROCK, CO. DUBLIN
L2
IRELAND
0
1
0
0
VP Clinical&Regulatory Affairs
Ordinary Shares
2015-07-01
4
M
0
2098
.125
A
17890
D
Restricted Share Units
.125
2015-07-01
4
M
0
2098
0
D
2015-07-01
2019-07-01
Ordinary Shares
2098
7343
D
2,098 Restricted Share Units vested and became convertible on 7/1/15 and 2,098 Restricted Share Units will vest and be convertible on each of 7/1/16 and 7/1/17; The remaining 3,147 Restricted Share Units will vest and be convertible on 12/31/15.
/s/ Colin Giles by Geraldine T. Farrell, Attorney-in-Fact
2015-07-02